High Quality Biosimilars
Improving Global Healthcare Access
Target Biosimilars is a biotechnology company focused on improving global healthcare access through the development of high quality biosimilars.
01
Reduce healthcare costs
Expand patient access to biologic therapies in markets where biosimilars remain limited.
02
Extensive regulatory, clinical, & manufacturing experience
Previous roles at organisations such as the MHRA and Samsung Biologics.
03
Integrated GMP manufacturing, regulatory strategy & biosimilar development expertise
Delivering reliable, high quality biologic medicines.
There's more ahead than just financial goals
We work to understand your issues and are driven to ask better questions in the pursuit of making work.
Leverage agile frameworks to provide a robust synopsis for high level overviews. Iterative approaches to corporate strategy foster collaborative thinking to further the overall.
Value proposition organically grow the holistic world view of disruptive innovation via workplace diversity and empowerment. Bring to the table win-win survival.
99%
Modeling and Analytics
99%
Newest Financing Options
99%
Best Financing Solutions
Chief Operating Officer, Target Biosimilars
Anthony Newcombe, PhD
Target Biosimilars is co-founded by Dr Anthony Newcombe, a biologics regulatory CMC and compliance expert with over 25 years of experience in development, GMP manufacturing, regulatory CMC, auditing and compliance.
Anthony’s background includes senior operational and quality leadership roles in global pharmaceutical and biotechnology organisations including GSK, Pfizer and Samsung Biologics. His experience covers biologics, vaccines, antibody-drug conjugates (ADCs) and advanced therapy medicinal products (ATMPs), with a focus on building compliant and efficient GMP manufacturing operations that meet EU, FDA and global regulatory expectations.
Biologics Expert
Anthony has held executive leadership roles with responsibility for global CMC, GMP manufacturing and quality operations across multiple international organisations. At Samsung Biologics, he was part of the site leadership team overseeing technology transfers and GMP manufacturing at the world’s largest monoclonal antibody production facility. He has also provided strategic oversight to support the development and regulatory approval of several biologics, including the first biosimilar monoclonal antibody approved in the European Union and the first FDA approved autologous cell therapy.
Extensive Global Experience
Anthony has held senior operational and quality leadership roles including Chief Operating Officer at VectorY Therapeutics, Senior Director of CMC & Programme Management at Samsung Biologics and Senior Vice President of Manufacturing at POLUS Inc. He has managed large-scale biologics and biosimilar manufacturing operations and led technology transfers to support global GMP compliance.
His regulatory experience includes participation in inspections and scientific advice meetings with agencies such as the FDA and EMA. Anthony holds a PhD in Biochemistry from the MRC National Institute for Medical Research in London and has authored more than 30 scientific and technical publications.
With a career spanning biopharmaceutical development, GMP compliance and manufacturing operations, Anthony brings extensive operational and strategic experience to Target Biosimilars’ mission of developing high-quality, accessible biosimilar medicines through scientific excellence and global manufacturing expertise
Case studies
We help you weather today's uncertainty through our best team intelligence and needs.
Our team is a diverse network of consultants and industry professionals with a global mindset and a collaborative culture. We work to understand your issues and are driven to ask better questions in the pursuit of making your business work better.
Business Process Consulting
We are a young and creative company and we offer you fresh ideas for business.
With many types of mortgages and interest rates on the market, it can be confusing to know which one is right for you, so we’ve outlined some of the basic below. Your goals are individual.
